Graneodin F Tablet 8.75mg With 16 (Flurbiprofen)

Category

Prescription medications

Line

Non-steroidal anti-inflammatory drugs

Brand

Graneodin F

Molecule

Flurbiprofen

Presentation

8.75 mg lozenge, box with 16 tablets

Laboratory

Bristol Myers Squibb

Indications

Graneodin F is indicated for the treatment of inflammatory and painful processes of various etiologies. It is used in the management of conditions such as arthritis, tendinitis, and postoperative pain. It is also effective in the treatment of acute and chronic pain, as well as in conditions that require rapid relief of inflammation and pain. Its anti-inflammatory and analgesic action makes it a therapeutic option in situations requiring effective reduction of inflammation and discomfort.

Composition

Each Graneodin F lozenge contains 8.75 mg of flurbiprofen as the active ingredient, as well as excipients that facilitate its formulation and administration.

Contraindications

This medication is contraindicated in patients with hypersensitivity to flurbiprofen or to any of the excipients in the formulation. It should not be administered to patients with a history of gastric ulcers or gastrointestinal bleeding, as well as those with severe renal or hepatic insufficiency. Its use is not recommended during pregnancy and lactation, except in strictly necessary cases and under medical supervision.

Precautions

Caution should be exercised when administering Graneodin F to patients with a history of cardiovascular disease, hypertension, or gastrointestinal problems. It is important to conduct medical follow-up in patients requiring prolonged treatment, as well as to monitor renal and hepatic function during the use of this medication.

Storage

Store in a cool, dry place, at room temperature, protected from light and humidity. Keep out of reach of children.

Consult your doctor.

Prescription required.